News Focus
News Focus
Followers 231
Posts 21726
Boards Moderated 1
Alias Born 08/03/2006

Re: None

Tuesday, 11/09/2010 11:49:48 AM

Tuesday, November 09, 2010 11:49:48 AM

Post# of 1076
9:03AM ACADIA Pharmaceuticals awarded $300K Grant from The Michael J. Fox Foundation for the development of novel Nurr1-RXR agonists to treat parkinson's disease (ACAD) 0.71 :

ACADIA Pharmaceuticals Inc.(NasdaqGM: ACAD)
Real Time 0.7389 0.0236 (3.30%) 11:45AM EST

Last Trade: 0.7358
Trade Time: 11:28AM EST
Change: 0.0205 (2.87%)
Prev Close: 0.72
Open: 0.72
Bid: 0.7358 x 100
Ask: 0.7359 x 200
1y Target Est: 1.50
Day's Range: 0.70 - 0.7380
52wk Range: 0.70 - 2.00
Volume: 112,274
Avg Vol (3m): 265,138
Market Cap: 28.23M
P/E (ttm): N/A
EPS (ttm): -0.72
Div & Yield: N/A (N/A


Do your research! Play the TA. All posts are my opinion.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today